Quick Answer
AYTU BIOPHARMA, INC reported Net Income of -$13.56 million for fiscal year 2025.
AYTU BIOPHARMA, INC Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$13.56M | +14.4% |
| 2024 | -$15.84M | +7.1% |
| 2023 | -$17.05M | +84.3% |
| 2022 | -$108.78M | -86.6% |
| 2021 | -$58.29M | -327.9% |
| 2020 | -$13.62M | +49.8% |
| 2019 | -$27.13M | -166.3% |
| 2018 | -$10.19M | +54.7% |
| 2017 | -$22.51M | +20.1% |
| 2016 | -$28.18M | -264.9% |
| 2015 | -$7.72M | -38.4% |
| 2014 | -$5.58M | -9632.9% |
| 2013 | -$57.3K | +3.9% |
| 2012 | -$59.7K | +56.4% |
| 2011 | -$136.8K | -127.0% |
| 2010 | -$60.3K | -2.3% |
| 2009 | -$58.9K | -3.0% |
| 2008 | -$57.2K | -16.8% |
| 2007 | -$49.0K | +30.5% |
| 2006 | -$70.4K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$10.58M | -1443.1% | -638.6% |
| September 30, 2025 | $1.97M | +33.3% | -50.8% |
| March 31, 2025 | $3.99M | +238.3% | +406.9% |
| December 31, 2024 | $788.0K | +458.2% | -46.5% |
| September 30, 2024 | $1.47M | +118.2% | +151.1% |
| March 31, 2024 | -$2.89M | +59.9% | -1212.3% |
| December 31, 2023 | -$220.0K | +96.7% | +97.3% |
| September 30, 2023 | -$8.12M | -1058.3% | -12.8% |
- AYTU BIOPHARMA, INC showed an increase of +14.4% in Net Income compared to the prior fiscal year.
- Over the 2006–2025 period, AYTU BIOPHARMA, INC’s net income has declined by 19153.0% (from -$70.4 thousand to -$13.56 million).
- The most recent figure is from AYTU BIOPHARMA, INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 23, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: